No Blockbuster in the Obesity Drug Market, but Fluctuation in Next Year?
The obesity drug market which was reorganized with a psychotropic appetite suppressant has not produced blockbuster for a long time.
It is understood because of strong regulatory policies regarding psychotropic appetite suppressant and lower performance of the highlighted drugs such as Roche Xen...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
